Ben Kopp MD/MPH
@kidslungdoc.bsky.social
190 followers
120 following
32 posts
Physician scientist at Emory/ Children’s Healthcare of Atlanta. Co-Director of CF-AIR and Director Pulmonary Sickle Cell Program. Christian, champion for children and environmental health
Posts
Media
Videos
Starter Packs
Reposted by Ben Kopp MD/MPH
Ben Kopp MD/MPH
@kidslungdoc.bsky.social
· Aug 27
Ben Kopp MD/MPH
@kidslungdoc.bsky.social
· Aug 27
Ben Kopp MD/MPH
@kidslungdoc.bsky.social
· May 15
Altered nasal and oral microbiomes define pediatric sickle cell disease - PubMed
The oral and nasal cavities are susceptible to environmental exposures including pathogenic microbes. In individuals with systemic disorders, antibiotic exposure, changes to the immune system, or chan...
pubmed.ncbi.nlm.nih.gov
Reposted by Ben Kopp MD/MPH
Alondra Nelson
@alondra.bsky.social
· Feb 8
Excellent 🧵 on this evening's NIH announcement of a dramatic reduction in indirect rates for research institutions, which amounts to a generational restructuring of the US research and development ecosystem. These cuts are effective immediately, not just for new grants but for existing ones.
6. The policy does not just affect funding going forward. All existing NIH grants will have their indirect rates cut to 15% as of today, the date of issuance.
For a large university, this creates a sudden and catastrophic shortfall of hundreds of millions of dollars against already budgeted funds.
For a large university, this creates a sudden and catastrophic shortfall of hundreds of millions of dollars against already budgeted funds.
Reposted by Ben Kopp MD/MPH
Reposted by Ben Kopp MD/MPH
Ben Kopp MD/MPH
@kidslungdoc.bsky.social
· Dec 20
Papilledema in Children With Cystic Fibrosis Receiving Elexacaftor/Tezacaftor/Ivacaftor: A Multicenter Case Series - PubMed
Following the approval of elexacaftor/tezacaftor/ivacaftor (ETI), there have been post-marketing reports and published cases of papilledema and intracranial hypertension in children with cystic fibros...
pubmed.ncbi.nlm.nih.gov
Ben Kopp MD/MPH
@kidslungdoc.bsky.social
· Dec 16
Ben Kopp MD/MPH
@kidslungdoc.bsky.social
· Dec 14
Ben Kopp MD/MPH
@kidslungdoc.bsky.social
· Dec 11
Glycemia and Insulin Secretion in Cystic Fibrosis Two Years After Elexacaftor/Tezacaftor/Ivacaftor: PROMISE-ENDO - PubMed
After two years of ETI, fasting glucose and HbA1c showed modest decreases. Glucose tolerance varied, and overall measures of insulin secretion did not deteriorate.
pubmed.ncbi.nlm.nih.gov